CD4 Decline Is Associated With Increased Risk of Cardiovascular Disease, Cancer, and Death in Virally Suppressed Patients With HIV

Impact of HIV-1 Subtype on CD4 Count at HIV Seroconversion, Rate of Decline, and Viral Load Set Point in European Seroconverter Cohorts

(2012) G. Touloumi et al.   CLINICAL INFECTIOUS DISEASES

Causes of death among Danish HIV patients compared with population controls in the period 1995–2008

(2012) M. Helleberg et al.   INFECTION

CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE

(2012)   PLOS MEDICINE

HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes

(2011) J. Bohlius et al.   BLOOD

Low Lymphocyte Count and Cardiovascular Diseases

(2011) J. Nunez et al.   CURRENT MEDICINAL CHEMISTRY

Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients

(2010) Amit C Achhra et al.   AIDS

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy

(2010) Amélie Guihot et al.   AIDS

CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era

(2010) Sara Lodi et al.   AIDS

Role of biomarkers in predicting CVD risk in the setting of HIV infection?

(2010) Signe W Worm et al.   Current Opinion in HIV and AIDS

Therapeutic implications of low lymphocyte count in non-ST segment elevation acute coronary syndromes

(2009) Julio Núñez et al.   European Journal of Internal Medicine

Cohort Profile: The Danish HIV Cohort Study

(2008) N. Obel et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells

(2008) M. Catalfamo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA